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Abstract
The Copper Metabolism MURR1 domain protein 1 (COMMD1) is a protein involved in multiple cellular pathways, including
copper homeostasis, NF-kB and hypoxia signalling. Acting as a scaffold protein, COMMD1 mediates the levels, stability and
proteolysis of its substrates (e.g. the copper-transporters ATP7B and ATP7A, RELA and HIF-1a). Recently, we established an
interaction between the Cu/Zn superoxide dismutase 1 (SOD1) and COMMD1, resulting in a decreased maturation and
activation of SOD1. Mutations in SOD1, associated with the progressive neurodegenerative disorder Amyotrophic Lateral
Sclerosis (ALS), cause misfolding and aggregation of the mutant SOD1 (mSOD1) protein. Here, we identify COMMD1 as a
novel regulator of misfolded protein aggregation as it enhances the formation of mSOD1 aggregates upon binding.
Interestingly, COMMD1 co-localizes to the sites of mSOD1 inclusions and forms high molecular weight complexes in the
presence of mSOD1. The effect of COMMD1 on protein aggregation is client-specific as, in contrast to mSOD1, COMMD1
decreases the abundance of mutant Parkin inclusions, associated with Parkinson’s disease. Aggregation of a polyglutamine-
expanded Huntingtin, causative of Huntington’s disease, appears unaltered by COMMD1. Altogether, this study offers new
research directions to expand our current knowledge on the mechanisms underlying aggregation disease pathologies.
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Introduction
The ubiquitously expressed COMMD1 protein is the founder
member of the Copper Metabolism MURR1 domain (COMMD)
protein family. This class of proteins comprises ten members, and
is highly conserved between eukaryotes and some protozoa [1].
Previously, COMMD1 was identified as a regulator of copper
homeostasis as deletion of COMMD1 resulted in an extensive
accumulation of copper in the liver of Bedlington terriers and mice
[2]. Various studies imply that COMMD1 controls copper
homeostasis via an interaction with ATP7B and ATP7A, two
copper-transporting proteins associated with the copper storage
disorders Wilson’s and Menkes disease, respectively. Interestingly,
whereas COMMD1 promotes the proteolysis of misfolded ATP7B
proteins [3], the expression and subcellular localization of
misfolded ATP7A mutants, and consequently their copper
transporting function, are improved by COMMD1 [4].
Accumulating evidence indicates that COMMD1 is also
involved in various other cellular pathways, including NF-kB
and hypoxia signalling, sodium transport, and intracellular
trafficking of membrane proteins such as the cystic fibrosis
transmembrane conductance regulator (CFTR)[5–11]. As a
scaffold protein, COMMD1 regulates the folding, stability,
ubiquitination, and proteolysis of its interaction partners, including
ATP7B and ATP7A, ENaC subunits, CFTR, RelA, and HIF-1a
[5,7,9,11–13]. Its chaperone-like function in the cellular protein
homeostasis biology is underlined by its association with the
ubiquitin-proteasome system (UPS).
Recently, we established the interaction between COMMD1
and the Cu/Zn Superoxide Dismutase 1 (SOD1), a ubiquitously
expressed metalloenzyme involved in the cellular antioxidant
defence [14]. The copper-dependent interaction between
COMMD1 and SOD1 leads to a suppression of SOD1
homodimerization resulting in a marked decline in SOD1
scavenging activity and consequently an induction of toxic
superoxide anions. At present, over 175 mutations in SOD1,
primary associated with an autosomal dominant inheritance
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pattern (for updated list, see http://alsod.iop.kcl.ac.uk/), have
been identified to cause the severe neurodegenerative disorder
amyotrophic lateral sclerosis (ALS) [15]. In general, the dispersed
mutations lead to misfolding and aggregation of the SOD1 protein
[16–19], which may interfere with normal cellular functions [20].
Similar as mutant SOD1 (mSOD1), intraneuronal accumulation
of misfolded Parkin and polyglutamine (polyQ)-expanded Hun-
tingtin (Htt) proteins is associated with the neurodegenerative
disorders Parkinson’s and Huntington’s disease, respectively [21–
26]. Although the processes underlying these aggregation disease
pathologies might share the gain-of-toxic aggregation as mecha-
nism of toxicity, the different misfolded proteins form biochem-
ically distinct aggregates [27], and affect different types of neurons
or neuronal areas (i.e. dopaminergic neurons in substantia nigra of
midbrain (Parkinson’s disease), medium spiny neurons in striatum
and frontal and temporal cortices (Huntington’s disease), or motor
neurons in spinal cord and brain stem (ALS)), thus resulting in
distinctive clinical phenotypes of these aggregation diseases.
Based on the established interaction of COMMD1 with SOD1,
and the present studies implicating a general role for COMMD1
in the protein quality control of various (misfolded) clients, we
assessed the effect of COMMD1 on the aggregation of the
aggregation-prone mutant SOD1, Parkin and Htt proteins. Here,
we show that COMMD1 co-localizes to and increases the
formation of mSOD1 aggregates. On the contrary, COMMD1
reduces the abundance of mutant Parkin C289G high molecular
weight (HMW) species, whilst it has no significant effect on
polyglutamine (polyQ)-expanded Htt aggregation.
Materials and Methods
Reagents
The following antibodies were used for immunoblotting:
monoclonal mouse-anti-Flag M2 and polyclonal mouse-anti-Flag
M2 HRP-conjugated (Sigma-Aldrich, St. Louis, MO, USA),
polyclonal rabbit-anti-GST (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), polyclonal mouse-anti-HA (Sigma-Aldrich),
rabbit-anti-COMMD1 antiserum [28], monoclonal mouse-anti-
GFP JL-8 (Clontech, Mountain View, CA, USA), monoclonal
mouse-anti-Parkin (Park8) (Cell Signaling, Danvers, MA, USA),
monoclonal mouse-anti-GAPDH (RDI Research Diagnostics,
Concord, MA, USA), and polyclonal mouse-anti-a-Tubulin
(Sigma-Aldrich).
Constructs
pEBB-HA-COMMD1, pEBB-COMMD1-Flag, mCherry-
COMMD1, COMMD1-GST, and pEBB-SOD1-Flag constructs
were described previously [14,29]. eGFP-N2 construct was
commercially obtained from Invitrogen Life Technologies Cor-
poration (Carlsbad, CA, USA). Mutations in pEBB-SOD1-Flag
WT were introduced by the Quickchange site-directed mutagen-
esis method (Stratagene, primer sequences are listed in Table S1).
pcDNA3.1-SOD1-YFP WT, G85R and G93A plasmids were
obtained from Dr. J. Frydman (Stanford, CA, USA). The
mutations were verified by automated DNA sequence analysis.
eYFP-HttQ74 encoding for the eYFP-tagged Huntingtin N-
terminal fragment of exon 1 with 74 CAG repeats was kindly
provided by Dr. D. C. Rubinsztein [30]. eYFP-HttQ119 and
DNAJB6 constructs were described previously [31]. The
pcDNA3.1-Flag-Parkin WT and C289G constructs were used as
described previously [32], and kindly provided by Dr. M.
Cheetham (UK).
Cell culture and transfections
Human embryonic kidney 293T (HEK293T), HeLa and mouse
neuroblastoma Neuro2A cells (all obtained from ATCC, Manas-
sas, VA, USA) were cultured in high-glucose Dulbecco’s modified
Eagle’s medium GlutaMAX-TM (4.5 g/L D-Glucose and
Pyruvate; Invitrogen Life Technologies Corporation) supplement-
ed with 10% fetal bovine serum (FBS), L-glutamine, penicillin and
streptomycin at 37uC in 5% CO2. Monoclonal HEK293T cell
lines, stably transfected with pSUPER-RETRO vector (shControl)
or a plasmid encoding short hairpin RNA (shRNA) targeting
COMMD1 mRNA sequence (shCOMMD1), were described
previously [33] and maintained in HEK293T medium supple-
mented with 1 mg/ml puromycin dihydrochloride (Sigma-Aldrich).
For copper-dependent interaction studies, cells were incubated
overnight with 150 mM CuCl2 prior to lysis.
Cells were transiently transfected by the calcium phosphate
precipitation method or FUGENE HD transfection method
(Roche, Basel, Switzerland), according to manufacturer’s instruc-
tions. Unless stated otherwise, cells were harvested 48 h after
transfection for biochemical analysis.
GST pull down assays and immunoblot analyses
Precipitation of GST-tagged proteins by means of GSH-
sepharose beads was performed as described previously [14]. In
short, transiently transfected cells were rinsed once with PBS prior
to lysis in lysisbuffer A (25 mM HEPES; pH 7.9, 100 mM NaCl,
1 mM NaEDTA, 1% Triton X-100, 10% Glycerol) supplemented
with 1 mM Na3VO4, 1 mM PMSF, 10 mM DTT and protease
inhibitors (Complete; Roche). For lysis of copper-treated cells, lysis
buffer A was supplemented with 1 mM CuCl2. Protein concen-
trations were determined by Bio-Rad (Bradford) Protein Assay
(Bio-Rad Laboratories Inc., Hercules, CA, USA). In all interaction
studies, equal amounts of proteins in lysisbuffer A were used for
precipitation. Protein lysates were boiled at 95uC prior to gel
loading, and SDS–PAGE was followed by proteins transfer onto
nitrocellulose membranes (Schleicher & Schuell,‘s-Hertogenbosch,
the Netherlands) for immunoblot analysis. Input samples represent
approximately 1% of protein amounts used for GST-precipitation.
Visualization of protein multimeric complexes and
aggregates
Visualization of SOD1 monomers, dimers and multimers by
means of non-reducing SDS-PAGE was performed as described
previously [14]. Aggregates of SOD1 mutant proteins were
visualized by means of filter trap analysis as described by Niwa
et al. [34] with slight modifications. In short, cells were lysed in
lysisbuffer B (50 mM Tris-HCL, pH 8.0; 150 mM NaCl; 1 mM
EDTA and 1% NP-40) supplemented with protease inhibitors
(Complete; Roche). After centrifugation, supernatant was separat-
ed from pellet, and the pellet was dissolved in Buffer C (50 mM
Tris-HCL, pH 8.0; 1 mM MgCl2) supplemented with ,250 U
Benzonase endonuclease (Merck Chemicals, Darmstadt, Ger-
many) for 1 h at 37uC. To complete pellet dissolvement, samples
were subsequently incubated with Buffer D (Buffer B supplement-
ed with 2% SDS) on a shaking platform for 1 h prior to addition of
Buffer E (40 mM EDTA supplemented with 4% SDS). 40 mg
protein lysate was applied on 0.2 mm cellulose acetate membranes,
prewashed with TBS-0.1% SDS, following detection of proteins by
means of immunoblotting. Blue Native PAGE experiments were
performed using precast NativePAGE Novex 4–16% Bis-Tris Gels
(Invitrogen Life Technologies Corporation), according to manu-
facturer’s guidelines. For polyQ experiments, filter trap assay was
used to assess HMW species as described previously [31]. PolyQ
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and Parkin samples were lysed after 24 h in 1% (v/v) Triton X-100
in PBS containing 1% (v/v) proteinase inhibitor cocktail for 15
min on ice. Cell lysates were scraped and centrifuged at 13.000 g
for 15 min at 4uC. The supernatant was used as soluble fraction
and the pellet was resuspended in 1% SDS buffer, sonicated, and
used as insoluble or pellet fraction.
Confocal Microscopy
For immunofluorescence, cells were grown on coverslips pre-
coated with poly-L-lysine (Sigma-Aldrich) prior to washing the
cells once in ice-cold PBS and fixation using 4% (w/v)
paraformaldehyde for 20 min at 4uC 72 h post-transfection.
Subsequently, coverslips were mounted using Immu-Mount
(Thermo Fisher Scientific, Houston, TX, USA). Images were
acquired using a LSM510 Meta confocal microscope (Carl Zeiss,
Jena, Germany) equipped with a 63x/1.40 N.A. Plan-Apochromat
oil-objective by sequential excitation at 488 and 561 nm.
Statistical analysis
Relative protein expressions and interaction strengths were
quantified using densitometry (GS-700; Bio-Rad). The quantita-
tive data in this paper is represented as means 6 SD. Statistical
evaluation was made using a paired One-way ANOVA with
Dunnett’s multiple comparison test (Figure 1B) and paired
Student’s t-test. Differences we-re considered to be significant at
p,0.05.
Results
Enhanced interaction of COMMD1 with ALS-associated
SOD1 mutants compared to SOD1 wild-type
To assess a potential effect of altered COMMD1 expression for
the fate of mutant SOD1, we first examined the interaction of
COMMD1 with a range of mSOD1 proteins associated with ALS
(A4V, G37R, G85R, D90A, G93A and E100G) by means of GST
pull down studies in HEK293T cells. The SOD1 mutants studied
were selected as they are located in distinct regions of the SOD1
protein, and associated with an ALS disease pathology in
transgenic rodent models [35–40]. With the exception of mSOD1
D90A, a significant increase in COMMD1 binding to the SOD1
mutants compared to SOD1 WT was observed (Figure 1A).
Quantification of the interactions, which was corrected for SOD1
input levels, demonstrated that the binding of the mSOD1
proteins to COMMD1 was up to a 5-fold enhanced compared to
SOD1 WT (Figure 1B). To assess whether the enhanced
interaction of COMMD1 with SOD1 mutants was not due to
any potential sedimentation of the aggregating mSOD1 proteins
during low speed centrifugation, we confirmed the increased
COMMD1-mSOD1 association in additional GST pull down
studies using glutathione magnetic beads (Figure S1A). Consistent
with the precipitation of mSOD1-GST proteins, the enhanced
binding of COMMD1 to mSOD1 was established bidirectionally
as co-immunoprecipitation of mSOD1-Flag by COMMD1-GST
using glutathione magnetic beads also clearly identified the
COMMD1-(m)SOD1 interaction (Figure S1B). In contrast to its
interaction with SOD1 WT [14] and mSOD1 D90A, the binding
of COMMD1 to all studied mSOD1 proteins occurred indepen-
dently of copper (Figure 1C, S1C, and data not shown).
COMMD1 modulates the aggregation of SOD1 mutants
Since mSOD1 proteins are susceptible to aggregate formation, a
pathological hallmark of ALS, we determined whether COMMD1
expression affects mSOD1 the formation of SDS-insoluble
aggregates by means of filter trap analysis. In contrast to SOD1
WT and mSOD1 D90A, the mSOD1 proteins formed SDS-
insoluble aggregates in HEK293T cells. Co-expression of
COMMD1 significantly increased the formation of these SDS-
insoluble mSOD1 aggregates (Figure 2A; upper panel). To rule
out the possibility that the effect of COMMD1 on mSOD1
aggregation is due to elevated expression of mSOD1, we analysed
the total mSOD1 protein levels by Western blot analysis. Except
for the A4V mutant, which showed a slight increase upon
COMMD1 co-transfection, all other mutants were either unaf-
fected or even showed reduced expression in the presence of
COMMD1 (Figure 2A; lower panel). Similar to the effect in
HEK293T cells, COMMD1 also augmented mSOD1 aggregation
in the neuroblastoma cell line Neuro2A, as demonstrated by
mutants G85R and G93A (Figure 2B). The inverse was observed
upon reduction of the endogenous COMMD1 expression in
HEK293T cells using shRNA, which significantly suppressed the
formation of mSOD1 aggregates without affecting mSOD1 levels
(Figure 2C).
COMMD1 promotes the formation of multimeric mSOD1
complexes
Next, we investigated whether COMMD1 also affects SOD1
dimerization and the formation of multimeric mSOD1 complexes
using non-reducing SDS-PAGE analysis. In line with the filter trap
assay, the majority of the mSOD1 proteins studied formed
extensive amounts of HMW complexes in HEK293T cells, which
were markedly increased by expression of COMMD1. This
occurred at the expense of loss of the dimeric and monomeric
forms of SOD1 (Figure 3A; – b-ME); again, this was not due to an
increase in mSOD1 expression as in fact the total protein levels of
most of the mutants were reduced (Figure 3A; + b-ME). Of note,
in presence of the reducing agent (+b-ME), no mSOD1 HMW
species were detected at the top, nor in the stacking, of the SDS-
PAGE gels, indicating that all mSOD1 HMW species are
concentrated in the monomeric form (data not shown). Mutant
D90A did not show substantial HMW complexes and these were
also not induced by COMMD1. However, similar to what we
previously have demonstrated for SOD1 WT ([14] and Figure 3B),
COMMD1 reduced the formation of mSOD1 D90A homodimers
(Figure 3A). Analogous to HEK293T cells, exogenous expression
of COMMD1 also resulted in an increase of multimeric mSOD1
complexes in Neuro2A cells as illustrated by the SOD1 mutants
G85R and G93A (Figure 3C).
Interestingly, COMMD1 co-localizes to mSOD1 inclusions
using confocal microscopy analysis (Figure 4A), while mCherry-
COMMD1 is not sequestered into puncta in cells expressing
SOD1 WT proteins (Figure 4A). This observation is strengthened
by the fact that COMMD1 co-migrates with multimeric mSOD1
on a blue native PAGE gel, whereas, in absence of mSOD1,
COMMD1 is only present as a monomeric protein as COMMD1
HMW species remain undetectable (Figure 4B). Together, these
observations may suggest that COMMD1 has to be in complex
with multimeric mSOD1 to accelerate mSOD1 aggregation.
COMMD1-mediated mSOD1 aggregation is dependent
on SOD1 Cys6
Previous studies are indicative for detergent-insoluble mSOD1
aggregates to contain molecules that are cross-linked by intermo-
lecular disulfide bonds, and that these promote the formation of
the mSOD1 HMW complexes [34,41–43]. However, these data
have recently been debated by other studies that only show
appearance of aberrant disulfide linkages in a late-disease state
[44–46]. SOD1 contains four cysteine residues. Whereas the
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cysteines at position 57 and 146 form an intramolecular disulfide
bond within the SOD1 monomer, the cysteines at position 6 and
111 can form intermolecular disulfide bonds and are suggested to
be involved in mSOD1 oligomer assembly [34,47]. To examine
whether intermolecular disulfide bond formation is associated with
the enhanced SOD1 aggregation in the presence of COMMD1,
cysteines 6 and 111 in the SOD1 sequence were mutated into a
serine (SOD1 C6S and C111S, respectively), and their effect on
the SOD1 - COMMD1 interaction and COMMD1-mediated
aggregation was established. Interestingly, binding of COMMD1
to SOD1, both WT and ALS-linked mutants, was almost
completely abolished by SOD1 C6S, whereas it remained
unaltered upon mutating the cysteine at position 111 (Figure 5A
(SOD1 WT) and B (mSOD1), and data not shown). Previously,
this C6S mutation drastically minimized the ability of mSOD1
G85R and G93A to form disulfide-linked HMW complexes,
whereas the effect of the C111S substitution in these proteins was
much less pronounced [34,48]. This, together with the knowledge
that the double SOD1 mutant C6S/G93A does not display any
aggregates, neither in the presence of exogenous COMMD1 ([34]
and Figure 5C), not only suggest that cysteine residue 6 of SOD1 is
essential for COMMD1 – mSOD1 interaction, but also for the
formation of mSOD1 aggregates. Noteworthy, an amino acid
substitution of the single cysteine present in the COMMD1
sequence into a serine (COMMD1 C160S) had no clear effect on
mSOD1 aggregation (data not shown), implying that the increased
Figure 1. Enhanced interaction of COMMD1 with ALS-associated SOD1 mutant proteins relative to SOD1 wild-type. A. HEK293T cells
were transient transfected with empty vector (EV), HA-COMMD1 alone or in combination with SOD1-GST constructs (WT, A4V, G37R, G85R, D90A,
G93A, E100G). GST-proteins were precipitated by means of GSH-sepharose beads prior to detection of their interaction with COMMD1 as visualized
by immunoblotting for HA-COMMD1 (GST PD; upper panel), as described previously [27]. 30 mg of protein lysates were used for detection of WT and
mutant SOD1-GST and HA-COMMD1 in total cell lysates (Input; lower panel) using antibodies directed against the HA- or GST-fusion proteins. Tubulin
was used as loading control. B. Densitometric quantification of interaction strength between COMMD1 and SOD1 WT versus SOD1 mutants (A4V,
G37R, G85R, D90A, G93A, E100G; GST PD), normalized for total SOD1 expression (input). Binding of COMMD1 to SOD1 WT was set at 1. * indicates
significantly increased binding of COMMD1 to mSOD1 compared to SOD1 WT – COMMD1 (* p,0.05, ** p,0.005, *** p,0.0001). n.s. = non-
significant. C. HEK293T cells were transient transfected with HA-COMMD1 alone or in combination with SOD1-GST constructs (WT and G93A). Cells
were incubated overnight under basal conditions or with 150 mM CuCl2, lysed, and GST fusion proteins were precipitated by means of GSH-sepharose
beads prior to detection of their interaction with COMMD1 as visualized by immunoblotting for HA-COMMD1 (GST PD; upper panel). 30 mg of protein
lysates were used for detection of SOD1-GST WT and G93A and HA-COMMD1 in total cell lysates (Input; lower panel) using antibodies directed
against the HA- or GST-tags.
doi:10.1371/journal.pone.0092408.g001
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Figure 2. COMMD1 mediates aggregation of ALS-associated SOD1 mutants. A. SOD1-Flag WT and mutant (A4V, G37R, G85R, D90A, G93A,
E100G) constructs were co-transfected with either EV (–) or HA-COMMD1 in HEK293T cells prior to detection of SOD1 aggregates by means of filter
trap analysis on cellulose acetate membrane as described in Experimental procedures section (40 mg protein; upper panel). Aggregates were
analysed on the same membranes and visualized by IB using antibodies directed against the Flag-tag. Input samples (15 mg protein; lower panel),
corresponding to the filter trap analysis, represent total cell lysates of each condition, and were visualized using antibodies directed against the Flag-
and HA-tag, and a-Tubulin, respectively. Input samples were analysed on separated membranes. Graph represents the relative COMMD1-mediated
induction in SOD1 aggregates compared to EV conditions (representative for at least 3 independent experiments). EV, SOD1 WT and mSOD1 D90A
values were considered as 0 as these proteins do not form aggregates. * indicates significantly increase in mSOD1 aggregation mediated by
COMMD1 (** p,0.005, *** p,0.001, **** p,0.0001). n.s. = non-significant. B. Filter trap analysis of Neuro2A cells transiently transfected with SOD1-
Flag mutants G85R and G93A in combination with either EV (–) or HA-COMMD1. Detection of aggregates and input samples was performed as
described in Figure 2A. Graph represents the relative COMMD1-mediated induction in mSOD1 aggregates compared to EV conditions (representative
for at least 3 independent experiments). * indicates significantly increase in mSOD1 aggregation mediated by COMMD1 (* p,0.05). C. Filter trap
analysis performed in HEK293T cells stably transfected with shControl or shCOMMD1 and co-transfected with SOD1-Flag WT and mutants (A4V, G37R,
G85R, D90A, G93A, E100G). Aggregates were analysed on the same membranes. Analyses were performed as described in Figure 2A. Input samples
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aggregation of mSOD1 by COMMD1 is unlikely resulting from
intermolecular disulfide linkages.
COMMD1 mediates aggregate formation in a client-
specific manner
Next, we assessed whether COMMD1 also affects the aggregate
deposition of other aggregation-prone misfolded proteins, such as
a Parkin RING domain mutant (C289G) associated with
Parkinson’s disease. Consistent with previous findings, the fraction
of Parkin ending up in the Triton-insoluble pellet fraction is
dramatically enhanced upon this cysteine to glycine substitution at
position 289 as detected by SDS-PAGE; in this insoluble fraction,
there is an increase in Parkin-containing HMW species, all
indicative of aggregation ([25] and Figure 6A; pellet fraction). In
contract to what we found for mSOD1, ectopically expressed
were analysed on separated membranes. Indicated values represent the relative COMMD1-mediated reduction in mSOD1 aggregates compared to
EV conditions (mSOD1 aggregation upon EV co-transfection was set a 1.0; representative for at least 3 independent experiments). EV, SOD1 WT and
mSOD1 D90A values were considered as 0 as these proteins do not form aggregates. Graph represents the relative COMMD1-mediated reduction in
SOD1 aggregates compared to EV conditions (representative for at least 3 independent experiments). EV, SOD1 WT and mSOD1 D90A values were
considered as 0 as these proteins do not form aggregates. * indicates significantly decrease in mSOD1 aggregation upon COMMD1 knock-down (*
p,0.05, ** p,0.005, **** p,0.0001). n.s. = non-significant.
doi:10.1371/journal.pone.0092408.g002
Figure 3. Formation of mSOD1 high molecular mass species is regulated by COMMD1. A. HEK293T cells were co-transfected with SOD1-
Flag mutants (A4V, G37R, G85R, D90A, G93A, E100G) in combination with EV (–) or HA-COMMD1 prior to lysis and detection of SOD1 multimeric
complexes using SDS-PAGE under non-reducing conditions (– b-ME; 40 mg). Immunoblotting was performed using antibodies directed against the
Flag-tag and HA-COMMD1 proteins. Input samples were analysed in presence of b-ME (+ b-ME; 30 mg). Samples were analysed on separated
membranes. B. HEK293T cells were co-transfected with SOD1-Flag WT in combination with EV (–) or HA-COMMD1 prior to lysis and analysed as
described in Figure 3A. C. Visualization of SOD1 HMW complexes in Neuro2A cells transfected with SOD1-Flag mutants G85R and G93A in
combination with EV (–) or HA-COMMD1 as described in Figure 3A. Samples were analysed on separated membranes.
doi:10.1371/journal.pone.0092408.g003
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Figure 4. COMMD1 is in complex with aggregated mSOD1 proteins. A. Neuro2A cells were transient transfected with eYFP-tagged SOD1
WT, or mSOD1 G85R and G93A, with or without mCherry-COMMD1, as indicated. 72 h post-transfection, cells were fixed and imaged using a confocal
microscope. B. HEK293T cells were transient transfected with either EV (–) or HA-COMMD1 in combination with EV, or Flag-tagged mSOD1 G85R or
G93A constructs prior to lysis and detection of SOD1 multimeric complexes using blue native PAGE (30 mg). Immunoblotting was performed using
antibodies directed against the Flag-tag and HA-COMMD1 proteins. Total protein levels were analysed in presence of b-ME on a SDS-PAGE gel
(30 mg). Photoshop analysis was used to generate overlay, using a marked region on the membrane as focus point.
doi:10.1371/journal.pone.0092408.g004
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COMMD1 suppressed Parkin C289G aggregation (Figure 6A;
pellet fraction). Using a pull down assay, a clear interaction
between COMMD1 and Parkin WT as well as Parkin C289G was
detected; yet, the mutation in Parkin increased its binding to
COMMD1 (Figures 6B (GSH sepharose beads) and S2 (GSH
magnetic beads)), similar to what was seen for the SOD1 mutants
studied (Figure 1).
In contrast to mutant SOD1 and Parkin aggregates, COMMD1
has no clear effect on the aggregation of a fragment encoding the
N-terminal region of exon 1 of the Huntingtin gene with either 74 or
119 glutamine repeats (HttQ74 and HttQ119) associated with
Huntington’s disease. Consistent with the inability to identify an
interaction between COMMD1 and HttQ74 or HttQ119 proteins
(data not shown), no changes in the Htt HMW aggregating species
could be identified by Western blotting (HMW are trapped in the
stacking gel; Figure 7A), whilst, as a positive control, enhanced
expression of the DNAJ (Hsp40 homolog) chaperone family
protein DNAJB6 clearly reduced the polyQ aggregation (Figure
7A and [31]). A slight reduction in SDS-insoluble Htt aggregates
in cells expressing COMMD1 was determined though in a filter
retardation assay (Figure 7B). However, since COMMD1 does not
interact with Htt proteins and its effect on Htt aggregate formation
is only very minor if any, we believe that it is unlikely for
COMMD1 to be a modulator of polyQ-expanded Htt aggrega-
tion.
Together, these data imply that COMMD1 affects the
aggregation of the three tested disease-associated misfolded
proteins in a client-specific manner.
Discussion
Recent studies demonstrated that COMMD1 is involved in
different cellular processes, such as copper metabolism, sodium
transport, and NF-kB and HIF signalling. Here, we show a client-
specific role for COMMD1 on the aggregation of protein species
associated with the neurodegenerative disorders SOD1-linked
ALS, Parkinson’s disease and Huntington’s disease. Down
regulation of COMMD1 expression suppresses the deposition of
mSOD1, whereas exogenous COMMD1 exacerbates the abun-
dance of mSOD1 aggregates. Inversely, COMMD1 decreases the
aggregation of Parkin C289G, while aggregation associated with
the expression of polyQ-expanded Huntingtin was unaffected by
COMMD1.
Although the mechanism by which COMMD1 exerts its effect
on the aggregation-prone proteins needs further investigation, our
data suggest that the COMMD1-induced mSOD1 aggregation is
regulated by a physical interaction between COMMD1 and
misfolded mSOD1. This is supported by the increased COMMD1
binding to mSOD1 compared to SOD1 WT (Figure 1), and its co-
localization with mSOD1 aggregates (Figure 4). Furthermore,
COMMD1 binding to mSOD1 is lost upon substitution of SOD1
Figure 5. COMMD1-mediated induction of mSOD1 aggregation is affected by a SOD1 C6S substitution. A. HEK293T cells were transient
transfected with either EV (–) or HA-COMMD1 in combination with GST only or SOD1-GST constructs (WT, C6S, C111S). GST PD was performed as
described under Figure 1A. B. HEK293T cells were transient transfected with EV (–) or HA-COMMD1 in combination with GST only or SOD1-GST
constructs (WT, C6S, G93A, C6S/G93A, G85R, C6S/G85R). GST PD was performed as described under Figure 1A. C. Filter trap analysis of HEK293T cells
transiently transfected with SOD1-Flag mutants (C6S, G93A, C6S/G93A) in combination with either EV (–) or HA-COMMD1. Detection of aggregates
was performed as described in Figure 2A.
doi:10.1371/journal.pone.0092408.g005
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cysteine 6 into a serine. Similar results were seen for its binding to
SOD1 WT suggesting that SOD1 C6 is essential for COMMD1
interaction with both WT and mutant SOD1. This further implies
that COMMD1 interacts with monomeric or small oligomeric
mSOD1 proteins as its interaction is lost when the mSOD1
protein is unable to form intermolecular disulfide bonds. Since
SOD1 C6 is also important for the formation of detergent-
insoluble mSOD1 aggregates (Figure 5 and [34,47,48]), we cannot
conclude whether the loss-of-aggregation properties of the double
mSOD1 C6S/G93A affects the interaction between COMMD1
and mSOD1, or C6S substitution itself.
Yet, because of the irrelevance of cellular copper levels for the
binding of COMMD1 to mSOD1, which is in contrast to the
COMMD1- SOD1 WT interaction [14], the biochemical nature
of the COMMD1 interaction with WT and mutant SOD1 is
suggested to be distinct. This is underscored by mSOD1 G85R, a
mutation located within the metal-binding region of SOD1 [49–
51]. This mutation results in a lower copper affinity [52], but still
markedly increased the interaction between SOD1 and
COMMD1 (Figure 1). The finding that the copper chaperone
for SOD1 (CCS), which delivers copper to SOD1, is suggested not
to be required for mSOD1 aggregation in mice [38], whereas it is
essential for COMMD1-SOD1 WT binding [14], further supports
the different natures of COMMD1 binding to SOD1 WT and
mutant. ALS-linked mutations in SOD1 result of exposure of more
hydrophobic surfaces in the mSOD1 proteins, which enhances the
propensity for non-native interactions with itself and other proteins
and subsequent self- and co-aggregation [53,54], and this may be
the underlying mechanism driving the increased interaction of
COMMD1 with mSOD1. Subsequently, the formation of this
protein-protein complex intensifies the aggregation of proteins,
which appears to be initiated by mSOD1 (Figure 4). Of note,
COMMD1 has also the tendency to form HMW complexes with
itself and its substrates (data not shown, and [6,55,56]); in this case,
these are most likely exacerbated by mSOD1.
Previously, we demonstrated that binding of COMMD1 to
SOD1 WT reduces the level of SOD1 WT dimers [14], and dimer
dissociation is shown to initiate SOD1 aggregation in vitro [57,58].
Additionally, co-expression of SOD1 WT exacerbates the disease
phenotypes of mSOD1 mice (i.e. A4V, G85R, G93A)[59,60],
Figure 6. COMMD1 diminishes Parkin C289G aggregation. A. HEK293T cells were transfected with Parkin WT and C289G constructs alone, or
in combination with HA-COMMD1. Supernatant (Sup) and pellet fractions were prepared as described in Experimental procedures. Immunoblotting
was performed using indicated antibodies. Graphs represent relative fraction of insoluble Parkin proteins in absence or presence of exogenous
COMMD1 (fractions quantified from both Parkin as well as Flag immunoblots). B. HEK293T cells were transient transfected with GST or COMMD1-GST
alone in combination with Flag-Parkin constructs (WT and C289G). Cells were lysed, and GST fusion proteins were precipitated as described under
Figure 1A. Immunoblotting was performed using indicated antibodies. Densitometric quantification of interaction strength between COMMD1 and
Parkin WT versus C289G mutant, normalized for total Parkin expression (input). Binding of COMMD1 to Parkin WT was set at 1.
doi:10.1371/journal.pone.0092408.g006
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while mice overexpressing SOD1 WT alone are not characterized
by paralysis or premature death [59]. Therefore, despite the fact
that a mutation in SOD1 enhances its interaction with COMMD1,
we cannot rule out that the COMMD1-mediated reduction in
endogenous SOD1 dimers and thus the expansion in monomeric
WT species cause the increased formation of mSOD1 aggregates.
Future structural and biochemical studies determining the effect of
COMMD1 on mSOD1 aggregation in the absence of endogenous
SOD1 are needed to provide further insight into the mechanism
by which both COMMD1 and SOD1 WT affect mSOD1
aggregation.
Interestingly, our findings show that COMMD1 modifies
misfolded protein aggregation in a client-specific manner. These
data support the idea that the biochemical and biophysical
properties of the various aggregation-prone proteins studied are
substantially different, which may explain the client-specific
actions of COMMD1. Unlike pathogenic Htt, mSOD1 proteins
initially do not form dense, ordered amyloid-like fibrils but rather
arrange a distinct amorphous, porous aggregate structure [61].
Also, the different misfolded proteins are accumulating in various
cellular compartments when expressed in yeast or mammalian
cells [62,63]. Further support for this can be derived from the
differential ability of the multiple heat shock proteins (HSPs) to
reduce aggregation, which is highly depended on the aggregation-
inducing client, and from unbiased screens for modifiers of the
aggregate formation of different aggregation-prone proteins that
have shown only limited overlap [63].
The client-specific effects of COMMD1 was recently also
demonstrated in other studies. For example, we demonstrated that
COMMD1 enhances the protein degradation of ATP7B [3],
whereas COMMD1 improves the stability and copper transport-
ing activity of misfolded ATP7A mutants [14]. Based on this
knowledge, we suggest that COMMD1 improves the folding of
mutant Parkin C289G and thereby reduces its aggregation.
Alternatively, and not mutually exclusive, the aggregates of the
mutant Parkin may be related to a dominant negative effect on the
E3 ligase function of the protein, which may be prevented by
COMMD1 binding, resulting in effective degradation of Parkin
clients. This is further supported by recent findings demonstrating
that COMMD1 activates the Cullin-RING ligases (CRLs) by
antagonizing CAND1 (Cullin-associated Nedd8-dissociated pro-
tein 1, inhibitor that promotes dissociation of substrate-receptor
components from CRLs) [64]. In this way, COMMD1 could
promote the poly-ubiquitination of its substrates leading to their
enhanced degradation. It might be possible that COMMD1
enhances the proteolysis of mutant Parkin C289G, similar as was
Figure 7. Aggregation of polyglutamine proteins is unaffected by COMMD1. A. HEK293T cells were transfected with eYFP-HttQ74 and
eYFP-HttQ119 alone, or in co-expression with HA-COMMD1 or V5-DNAJB6 prior to lysis and detection of polyQ HMW complexes using SDS-PAGE.
HMW aggregating complexes were trapped and detected in the stacking gel. IB was performed using indicated antibodies. Samples were analysed
on the same membranes. Graph represents the relative fraction of insoluble HttQ74 and Q119 HMW species under EV conditions or upon co-
expression of COMMD1 or DNAJB6. Insoluble Htt HMW species present in EV conditions were set at 1. B. Filter trap analysis of HEK293T cells
transfected with the polyQ proteins eYFP-HttQ74 and eYFP-HttQ119, in co-expression with EV or HA-COMMD1. Samples were prepared as described
under Experimental procedures and diluted as indicated. Immunoblotting was performed antibodies directed against the eYFP-tag. Densitometric
quantification of insoluble fraction of HttQ74 and HttQ119, in absence or presence of exogenous COMMD1 (5x dilution). EV conditions were set at 1.
p = 0.0425, indicates a significant decrease in insoluble HttQ74 aggregates mediated by COMMD1. n.s. = non-significant.
doi:10.1371/journal.pone.0092408.g007
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found for ATP7B and HIF-1a [3,5]. However, in contrast to its
potential mode of action on Parkin proteins, no effect of
COMMD1 on the protein stability of either SOD1 WT or
mutants was observed ([14] and data not shown), which is
consistent with the COMMD1-mediated induction in mSOD1
aggregation. It is clear that more mechanistic and physiological
work will be needed to clarify both the mode of action as well as
substrate-specificity of COMMD1 in the context of protein
misfolding and aggregation, and what the consequences of these
actions are for the toxicity related to these different aggregates.
Altogether, our and other studies are suggestive for COMMD1
to be a scaffold-like protein that acts at a platform to modify the
characteristics and function of different proteins involved in
various cellular processes. From our data, it can be inferred that
COMMD1 should be included in the class of molecular
chaperones that modulate cellular proteostasis, and thus could
be a relevant player in the pathology of a range of protein-
aggregation diseases.
Appendix
GST pull down assays using magnetic beads
Precipitation of GST-tagged proteins by means of glutathione
magnetic beads was performed according to manufacturer’s
protocol. In short, transient transfected cells were rinsed once
with PBS prior to lysis in lysisbuffer A (25 mM HEPES; pH 7.9,
100 mM NaCl, 1 mM NaEDTA, 1% Triton X-100, 10%
Glycerol) supplemented with 1 mM Na3VO4, 1 mM PMSF,
10 mM DTT and protease inhibitors (Complete; Roche). For lysis
of copper-treated cells, lysis buffer A was supplemented with
1 mM CuCl2. Protein concentrations were determined by Bio-
Rad (Bradford) Protein Assay (Bio-Rad Laboratories Inc.,
Hercules, CA, USA). In all interaction studies, equal amounts of
proteins in lysisbuffer A were used for precipitation. GSH-
magnetic beads (Pierce biotechnology, Rockford, IL, USA) were
washed three times with cold binding/wash buffer (125 mM Tris-
HCL, 300 mM NaCl, pH 8.0) using a magnetic stand prior to 1.5
h incubation with lysates at 4uC on a rotating platform.
Subsequently, beads were collected using a magnetic stand,
supernatant was removed, and beads were washed 4 times with
binding/wash buffer. Elution was accomplished by two rounds of
incubation of beads with 50 mM reduced L-glutathione (Sigma
Aldrich) in binding/wash buffer, pH 8.0 for 10 min. Protein
lysates were boiled at 95uC prior to gel loading, and SDS–PAGE
was followed by proteins transfer onto nitrocellulose membranes
(Schleicher & Schuell,‘s-Hertogenbosch, the Netherlands) for
immunoblot analysis. Input samples represent approximately 1%
of protein amounts used for GST-precipitation.
Supporting Information
Figure S1 Enhanced interaction of COMMD1 with ALS-
associated SOD1 mutant proteins relative to SOD1 wild-
type. A. HEK293T cells were transient transfected with empty
vector (EV), HA-COMMD1 alone or in combination with SOD1-
GST constructs (WT, G85R, D90A, G93A). GST-proteins were
precipitated by means of GSH-magnetic beads prior to detection
of their interaction with COMMD1 as visualized by immuno-
blotting for HA-COMMD1 (GST PD; upper panel). 30 mg of
protein lysates were used for detection of WT and mutant SOD1-
GST and HA-COMMD1 in total cell lysates (Input; lower panel)
using antibodies directed against the HA- or GST-fusion proteins.
Graph represents densitometric quantification of interaction
strength between COMMD1 and SOD1 WT versus SOD1
mutants (G85R, D90A, G93A; GST PD), normalized for total
SOD1 expression (input). Binding of COMMD1 to SOD1 WT
was set at 1. B. HEK293T cells were transient transfected with
GST, COMMD1-GST alone or in combination with SOD1-Flag
constructs (WT, G85R, D90A, G93A). GST-proteins were
precipitated by means of GSH-magnetic beads prior to detection
of their interaction with SOD1 as visualized by immunoblotting
for SOD1-Flag (GST PD; upper panel). 30 mg of protein lysates
were used for detection of GST, COMMD1-GST, and WT and
mutant SOD1-Flag in total cell lysates (Input; lower panel) using
antibodies directed against the GST- or Flag-fusion proteins.
Graph represents densitometric quantification of interaction
strength between COMMD1 and SOD1 WT versus SOD1
mutants (G85R, D90A, G93A; GST PD), normalized for total
SOD1 expression (input). Binding of COMMD1 to SOD1 WT
was set at 1. C. HEK293T cells were transient transfected with
HA-COMMD1 in combination with SOD1-GST constructs (WT,
G85R, D90A, G93A). Cells were incubated overnight under basal
conditions (–) or with 150 mM CuCl2, lysed, and GST fusion
proteins were precipitated by means of GSH-magnetic beads prior
to detection of their interaction with COMMD1 as visualized by
immunoblotting for HA-COMMD1 (GST PD; upper panel).
30 mg of protein lysates were used for detection of SOD1-GST
WT and mutants and HA-COMMD1 in total cell lysates (Input;
lower panel) using antibodies directed against the HA- or GST-
tags.
(PDF)
Figure S2 Enhanced interaction of COMMD1 with
Parkin C289G mutant proteins relative to wild-type
Parkin. HEK293T cells were transient transfected with GST or
COMMD1-GST alone in combination with Flag-Parkin con-
structs (WT and C289G). Cells were lysed, and GST fusion
proteins were precipitated as described under Figure S1A.
Immunoblotting was performed using indicated antibodies.
(PDF)
Table S1 Oligonucleotide primers used in this study.
(DOCX)
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